World class leadership
Our pioneering founders, Experienced senior management team, and diverse board of directors comprise a virtual who’s who of scientific innovators, battle-tested executives and highly skilled directors.
Pioneering Founders
Prof Sir Marc Feldman
Co-Founder
- Pioneer of anti-TNF therapy, world’s biggest drug class ($40B/yr)
- Anti-TNF discovery of Remicade eventually led to Centocor’s acquisition by J&J for $4.9B
- International awards for biomedical innovations: Crafoord, Lasker, Canada Gairdner, Janssen, EU Inventor of the Year, Tang
- UK and Australian knighthood
- Fellow of Royal Society and Australian Academy of Science; member of National Academy of Sciences
Prof Lawrence Steinman
Co-Founder; Director
- Discovered role of integrins, which led to natalizumab (Tysabri, sold to Biogen for $3.25B), a highly effective treatment for MS and IBD
- Founder of Neurocrine Biosciences
- Board member of Centocor, sold to J&J for $4.9B
- International awards for biomedical innovations: Sasse, Dystel, Charcot, Cerami, Javits (twice)
- Member of National Academy of Medicine and National Academy of Sciences
Prof Jagdeep Nanchahal, MD, PhD
Co-Founder; Chairman of Clinical Advisory Board
- Pioneered the treatment of fibrosis of the hand (Dupuytren’s disease) by identifying TNF⍺ as a target
- Surgeon-scientist, leading Phase 2b/3 trial for Dupuytren’s disease funded by Wellcome Trust and UK Dept. of Health
- Fellow of the Royal College of PlasticSurgeons